Millennium Pharmacon International Tbk PT operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Millennium Pharmacon International Tbk PT with three other
drug stores in Asia:
Tibet Rhodiola Pharmaceutical Holding Company
sales of 1.26 billion Chinese Renmimbi [US$185.55 million]
of which 97%
was Pharmaceutical Business Trade),
GuangYuYuan Chinese Herbal Medicine Co Ltd
(1.21 billion Chinese Renmimbi [US$179.33 million]
of which 87%
was Drug Industry), and
China Pioneer Pharma Holdings Ltd
based in CHINA
(1.32 billion Chinese Renmimbi [US$194.41 million]
of which 75%
was Products sold via the provision of compr).
Millennium Pharmacon International Tbk PT reported sales of 2.73 trillion Indonesian Rupiahs (US$185.15 million)
December of 2019.
increase of 14.8%
versus 2018, when the company's sales were 2.38 trillion Indonesian Rupiahs .
Sales at Millennium Pharmacon International Tbk PT have increased during each of the previous five years
(and since 2014, sales have increased a total of 90%).